Seeking Alpha

The marketing partner (Eisai ESALY.PK) for Arena's (ARNA) obesity-fighting Belviq has petitioned...

The marketing partner (Eisai ESALY.PK) for Arena's (ARNA) obesity-fighting Belviq has petitioned the DEA to expedite its approval process. If granted (this sort of request is rarely denied), this could have the drug in pharmacies on February 7, writes Joe Dedvukaj. Combined with what looks to be imminent EU approval, Street analysts will find themselves needing to catch up to lofty sales figures.
Comments (3)
  • tjellal
    , contributor
    Comment (1) | Send Message
     
    this is the best X-Mas gift we can get. 20$ pps is in very near future.
    24 Dec 2012, 08:56 AM Reply Like
  • deercreekvols
    , contributor
    Comments (5588) | Send Message
     
    Most analysts have missed on Arena in a major way.

     

    It seems that they took the word of Mr. Cramer instead of performing due diligence.

     

    Institutional buys tells a very different story on Arena.

     

    I am long ARNA and will enjoy an even better Christmas on this news.
    24 Dec 2012, 11:45 AM Reply Like
  • johnsnare
    , contributor
    Comments (19) | Send Message
     
    How high is up.?
    24 Dec 2012, 04:20 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector